Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Argus Health
Citi
Cerilliant
UBS
Federal Trade Commission
Fish and Richardson
Merck
US Department of Justice
Deloitte

Generated: January 22, 2018

DrugPatentWatch Database Preview

ARGATROBAN IN SODIUM CHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Argatroban In Sodium Chloride, and what generic alternatives are available?

Argatroban In Sodium Chloride is a drug marketed by Eagle Pharms, Gland Pharma Ltd, and Sandoz. and is included in three NDAs. There are two patents protecting this drug.

This drug has seven patent family members in five countries.

The generic ingredient in ARGATROBAN IN SODIUM CHLORIDE is argatroban. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the argatroban profile page.
Summary for ARGATROBAN IN SODIUM CHLORIDE
Drug patent expirations by year for ARGATROBAN IN SODIUM CHLORIDE
Pharmacology for ARGATROBAN IN SODIUM CHLORIDE

US Patents and Regulatory Information for ARGATROBAN IN SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eagle Pharms ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 022434-001 Jun 29, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Sandoz ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 022485-001 May 9, 2011 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Eagle Pharms ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 022434-001 Jun 29, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Gland Pharma Ltd ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 205570-001 May 22, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ARGATROBAN IN SODIUM CHLORIDE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Farmers Insurance
Moodys
Cerilliant
Baxter
Dow
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot